NasdaqGS - Delayed Quote USD
Nautilus Biotechnology, Inc. (NAUT)
0.7820
+0.0620
+(8.61%)
At close: 4:00:01 PM EDT
0.7800
-0.00
(-0.26%)
After hours: 6:58:56 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 42.1M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| PATEL SUJAL M Chief Executive Officer | Purchase at price 0.99 - 1.00 per share. | Direct | 76,918 | Mar 20, 2025 |
| GODWIN MARY ELIZABETH Officer | Conversion of Exercise of derivative security at price 0.46 per share. | Direct | 21,634 | Sep 23, 2024 |
| GODWIN MARY ELIZABETH Officer | Sale at price 2.86 per share. | Direct | 134,744 | Sep 23, 2024 |
| GODWIN MARY ELIZABETH Officer | Conversion of Exercise of derivative security at price 0.46 per share. | Direct | 16,100 | Sep 17, 2024 |
| GODWIN MARY ELIZABETH Officer | Sale at price 2.85 per share. | Direct | 99,869 | Sep 17, 2024 |
| PATEL SUJAL M Chief Executive Officer | Purchase at price 2.84 - 2.99 per share. | Direct | 41,478 | Mar 11, 2024 |
| PATEL SUJAL M Chief Executive Officer | Purchase at price 2.65 - 2.89 per share. | Direct | 99,054 | Mar 7, 2024 |
Related Tickers
CSJ.BE CSL Ltd
134.70
+0.07%
301080.SZ Acrobiosystems Co.,Ltd.
44.67
+1.89%
50BA.MU Bicycle Therapeutics PLC
6.80
0.00%
ZH6.BE Biohaven Ltd. R
18.60
+3.91%
B9A.MU BioArctic AB
15.18
0.00%
CSJ.MU CSL Ltd
132.78
-1.32%
A71.F Ascendis Pharma A/S
140.00
0.00%
REGN.VI Regeneron Pharmaceuticals, Inc.
505.40
+3.14%
LENZ LENZ Therapeutics, Inc.
25.79
+6.97%
ONTTF Oxford Nanopore Technologies plc
1.5610
0.00%